Thursday, 17 February 2011

Medical Representative PT Merck Tbk Indonesia

PT Merck Tbk is a leading multinational company in the pharmaceuticals and chemicals business in Indonesia.

Founded in 1970, PT Merck Tbk went public in 1981. The majority of the shares are held by the Merck Group, headquartered in Germany the oldest pharmaceutical and chemical company in the world.

In Chemical business, Merck markets a whole range of laboratory reagents, pigments and other specialty chemicals.

In pharmaceutical, we manufacture and markets well-known pharmaceutical brands such as Neurobion®, Sangobion® and Glucophage®.

To accelerate our growing business, our Consumer Health Care Division is looking for potential, dynamic and energetic candidates to fill the vacant position as:

Medical Representative (code: MR CH)


To promote our products & achieve sales target
Creating and maintaining good relationship with doctors & key persons
Actively participating in territory strategy  plan and objective making
Monitoring customer needs and customer motives
Making visit report and visit plan, and daily activity report
Motivated to develop product knowledge and selling skill


At Least Diploma 3 or Bachelor degree in any disciplines (pharmacy preferred).

Having at least 1 year working experience as Medical Representative in pharmaceutical business or FMCG.
Proactive and good networking.
Willing to travel and willing to work in the weekend and posses driving license (SIM C).
Negotiation & Presentation Skill.
Good interpersonal and communication skill.
Result oriented person.
Computer literate (MS Word, Excel, and Powerpoint).
Good command in English (oral and written).
Willing to be place in Jakarta Raya, Palembang, Purwokerto, Samarinda & Makassar

If you meet the above requirements, please submit your application, CV, related supporting documents, and a recent photograph, to:

PT. Merck Tbk Indonesia
Jl. TB Simatupang No. 8, Pasar Rebo, Jakarta Timur 13760
or by mail to :

Please put the code (MR CH) on the right top corner of your letter or on email subject

No comments:

Post a Comment

Subscribe via email

Enter your email address:

Delivered by FeedBurner